drugset / Trial / NCT06179732
Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities
Phase 3
Completed
2400 enrolled
The Mentor Initiative
Liverpool School of Tropical Medicine · collabSCJohnson · collabUS government · collabUniversity of Maiduguri · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to determine the effectiveness of a new spatial repellent (called Mesh) at repelling multiple disease vectors and, reducing clinical malaria rates in temporary shelters and camp settings. The design of the study will be a two-armed cluster randomised trial. By conducting the research in challenging camp settings in the north of Nigeria, the MENTOR Initiative aims to determine whether Mesh can be effective in harsh camp conditions where communities are living in conflict area temporary shelters.
Timeline
- Start
- 2023-06-05
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Outcome
Met primary endpoint
paper spatial repellent emanators significantly reduced malaria infection incidence over 6 months of follow-up (incidence rate ratio 0·713, 95% CI 0·584-0·869; p=0·001; PMID 41520670 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | transfluthrin | Small molecule | 2500 mg | Other |